发明名称 Bispecific SCFV Immunofusion (BIF)
摘要 Certain embodiments are directed to a bispecific immunoglobulin that is capable of binding cell surface molecules on a target cell, such as cancer cells, and cell surface molecules on immune effector cell, such as cytotoxic T lymphocytes, resulting in the targeted killing of target cells. In certain aspects a Bif is a polypeptide comprising a first target binding domain that specifically binds a cancer cell, a second effector binding domain that specifically binds an immunologic effector, and an immunoglobulin constant region linker operatively coupling the first and second binding domain.
申请公布号 US2015110789(A1) 申请公布日期 2015.04.23
申请号 US201314402009 申请日期 2013.05.18
申请人 Scott & White Healthcare 发明人 Liu Jen-Sing;Kuo Shu-Ru
分类号 C07K16/30;C07K16/28 主分类号 C07K16/30
代理机构 代理人
主权项 1. A polypeptide comprising a first target binding domain that specifically binds a cancer cell, a second effector binding domain that specifically binds an immunologic effector, and an immunoglobulin constant region linker operatively coupling the first and second binding domain.
地址 Temple TX US